|
|
xv | |
An overview of statistical causality |
|
xvii | |
|
|
|
|
1 Statistical causality: Some historical remarks |
|
|
1 | (5) |
|
|
|
1 | (1) |
|
|
2 | (1) |
|
|
2 | (1) |
|
1.4 An earlier controversy and its implications |
|
|
3 | (1) |
|
1.5 Three versions of causality |
|
|
4 | (1) |
|
|
4 | (2) |
|
|
4 | (2) |
|
2 The language of potential outcomes |
|
|
6 | (9) |
|
|
|
6 | (1) |
|
2.2 Definition of causal effects through potential outcomes |
|
|
7 | (2) |
|
2.2.1 Subject-specific causal effects |
|
|
7 | (1) |
|
2.2.2 Population causal effects |
|
|
8 | (1) |
|
2.2.3 Association versus causation |
|
|
9 | (1) |
|
2.3 Identification of population causal effects |
|
|
9 | (2) |
|
2.3.1 Randomized experiments |
|
|
9 | (2) |
|
2.3.2 Observational studies |
|
|
11 | (1) |
|
|
11 | (4) |
|
|
13 | (2) |
|
3 Structural equations, graphs and interventions |
|
|
15 | (10) |
|
|
|
15 | (1) |
|
3.2 Structural equations, graphs, and interventions |
|
|
16 | (9) |
|
|
16 | (1) |
|
|
17 | (2) |
|
3.2.3 Latent projections and semi-Markovian models |
|
|
19 | (1) |
|
3.2.4 Interventions in semi-Markovian models |
|
|
19 | (1) |
|
3.2.5 Counterfactual distributions in NPSEMs |
|
|
20 | (2) |
|
3.2.6 Causal diagrams and counterfactual independence |
|
|
22 | (1) |
|
3.2.7 Relation to potential outcomes |
|
|
22 | (1) |
|
|
23 | (2) |
|
4 The decision-theoretic approach to causal inference |
|
|
25 | (18) |
|
|
|
25 | (1) |
|
4.2 Decision theory and causality |
|
|
26 | (2) |
|
4.2.1 A simple decision problem |
|
|
26 | (1) |
|
|
27 | (1) |
|
|
28 | (1) |
|
|
29 | (4) |
|
|
29 | (1) |
|
|
30 | (1) |
|
|
31 | (2) |
|
|
33 | (1) |
|
4.6 Instrumental variable |
|
|
34 | (3) |
|
|
36 | (1) |
|
|
36 | (1) |
|
4.7 Effect of treatment of the treated |
|
|
37 | (1) |
|
4.8 Connections and contrasts |
|
|
37 | (3) |
|
4.8.1 Potential responses |
|
|
37 | (2) |
|
|
39 | (1) |
|
|
40 | (3) |
|
|
40 | (1) |
|
|
40 | (3) |
|
5 Causal inference as a prediction problem: Assumptions, identification and evidence synthesis |
|
|
43 | (16) |
|
|
|
43 | (1) |
|
5.2 A brief commentary on developments since 1970 |
|
|
44 | (2) |
|
5.2.1 Potential outcomes and missing data |
|
|
45 | (1) |
|
5.2.2 The prognostic view |
|
|
45 | (1) |
|
5.3 Ambiguities of observational extensions |
|
|
46 | (1) |
|
5.4 Causal diagrams and structural equations |
|
|
47 | (1) |
|
5.5 Compelling versus plausible assumptions, models and inferences |
|
|
47 | (3) |
|
5.6 Nonidentification and the curse of dimensionality |
|
|
50 | (1) |
|
5.7 Identification in practice |
|
|
51 | (2) |
|
5.8 Identification and bounded rationality |
|
|
53 | (1) |
|
|
54 | (5) |
|
|
55 | (1) |
|
|
55 | (4) |
|
6 Graph-based criteria of identifiability of causal questions |
|
|
59 | (12) |
|
|
|
59 | (1) |
|
6.2 Interventions from observations |
|
|
59 | (2) |
|
6.3 The back-door criterion, conditional ignorability, and covariate adjustment |
|
|
61 | (2) |
|
6.4 The front-door criterion |
|
|
63 | (1) |
|
|
64 | (1) |
|
6.6 General identification |
|
|
65 | (3) |
|
6.7 Dormant independences and post-truncation constraints |
|
|
68 | (3) |
|
|
69 | (2) |
|
7 Causal inference from observational data: A Bayesian predictive approach |
|
|
71 | (14) |
|
|
|
71 | (1) |
|
|
72 | (4) |
|
7.3 Extension to sequential regimes |
|
|
76 | (4) |
|
7.4 Providing a causal interpretation: Predictive inference from data |
|
|
80 | (2) |
|
|
82 | (3) |
|
|
83 | (1) |
|
|
83 | (2) |
|
8 Assessing dynamic treatment strategies |
|
|
85 | (16) |
|
|
|
|
|
85 | (1) |
|
|
86 | (1) |
|
8.3 Descriptive versus causal inference |
|
|
87 | (1) |
|
8.4 Notation and problem definition |
|
|
88 | (1) |
|
8.5 HIV example continued |
|
|
89 | (1) |
|
|
89 | (1) |
|
8.7 Conditions for sequential plan identifiability |
|
|
90 | (2) |
|
|
90 | (1) |
|
|
91 | (1) |
|
8.8 Graphical representations of dynamic plans |
|
|
92 | (2) |
|
8.9 Abdominal aortic aneurysm surveillance |
|
|
94 | (1) |
|
8.10 Statistical inference and computation |
|
|
95 | (2) |
|
|
97 | (1) |
|
|
98 | (1) |
|
|
99 | (2) |
|
|
99 | (1) |
|
|
99 | (2) |
|
9 Causal effects and natural laws: Towards a conceptualization of causal counterfactuals for nonmanipulable exposures, with application to the effects of race and sex |
|
|
101 | (13) |
|
|
|
|
101 | (1) |
|
9.2 Laws of nature and contrary to fact statements |
|
|
102 | (1) |
|
9.3 Association and causation in the social and biomedical sciences |
|
|
103 | (1) |
|
9.4 Manipulation and counterfactuals |
|
|
103 | (1) |
|
9.5 Natural laws and causal effects |
|
|
104 | (3) |
|
9.6 Consequences of randomization |
|
|
107 | (1) |
|
9.7 On the causal effects of sex and race |
|
|
108 | (3) |
|
|
111 | (3) |
|
|
112 | (1) |
|
|
112 | (2) |
|
10 Cross-classifications by joint potential outcomes |
|
|
114 | (12) |
|
|
|
114 | (1) |
|
10.2 Bounds for the causal treatment effect in randomized trials with imperfect compliance |
|
|
115 | (4) |
|
10.3 Identifying the compiler causal effect in randomized trials with imperfect compliance |
|
|
119 | (2) |
|
10.4 Defining the appropriate causal effect in studies suffering from truncation by death |
|
|
121 | (2) |
|
|
123 | (3) |
|
|
124 | (2) |
|
11 Estimation of direct and indirect effects |
|
|
126 | (25) |
|
|
|
126 | (1) |
|
11.2 Identification of the direct and indirect effect |
|
|
127 | (5) |
|
|
127 | (2) |
|
|
129 | (3) |
|
11.3 Estimation of controlled direct effects |
|
|
132 | (14) |
|
|
132 | (1) |
|
11.3.2 Inverse probability of treatment weighting |
|
|
133 | (4) |
|
11.3.3 G-estimation for additive and multiplicative models |
|
|
137 | (4) |
|
11.3.4 G-estimation for logistic models |
|
|
141 | (1) |
|
11.3.5 Case-control studies |
|
|
142 | (1) |
|
11.3.6 G-estimation for additive hazard models |
|
|
143 | (3) |
|
11.4 Estimation of natural direct and indirect effects |
|
|
146 | (1) |
|
|
147 | (4) |
|
|
147 | (1) |
|
|
148 | (3) |
|
12 The mediation formula: A guide to the assessment of causal pathways in nonlinear models |
|
|
151 | (29) |
|
|
12.1 Mediation: Direct and indirect effects |
|
|
151 | (6) |
|
12.1.1 Direct versus total effects |
|
|
151 | (1) |
|
12.1.2 Controlled direct effects |
|
|
152 | (2) |
|
12.1.3 Natural direct effects |
|
|
154 | (2) |
|
|
156 | (1) |
|
12.1.5 Effect decomposition |
|
|
157 | (1) |
|
12.2 The mediation formula: A simple solution to a thorny problem |
|
|
157 | (13) |
|
12.2.1 Mediation in nonparametric models |
|
|
157 | (2) |
|
12.2.2 Mediation effects in linear, logistic, and probit models |
|
|
159 | (5) |
|
12.2.3 Special cases of mediation models |
|
|
164 | (5) |
|
|
169 | (1) |
|
12.3 Relation to other methods |
|
|
170 | (3) |
|
12.3.1 Methods based on differences and products |
|
|
170 | (1) |
|
12.3.2 Relation to the principal-strata direct effect |
|
|
171 | (2) |
|
|
173 | (7) |
|
|
174 | (1) |
|
|
175 | (5) |
|
13 The sufficient cause framework in statistics, philosophy and the biomedical and social sciences |
|
|
180 | (12) |
|
|
|
180 | (1) |
|
13.2 The sufficient cause framework in philosophy |
|
|
181 | (1) |
|
13.3 The sufficient cause framework in epidemiology and biomedicine |
|
|
181 | (4) |
|
13.4 The sufficient cause framework in statistics |
|
|
185 | (1) |
|
13.5 The sufficient cause framework in the social sciences |
|
|
185 | (2) |
|
13.6 Other notions of sufficiency and necessity in causal inference |
|
|
187 | (1) |
|
|
188 | (4) |
|
|
189 | (1) |
|
|
189 | (3) |
|
14 Analysis of interaction for identifying causal mechanisms |
|
|
192 | (16) |
|
|
|
|
|
|
192 | (1) |
|
14.2 What is a mechanism? |
|
|
193 | (1) |
|
14.3 Statistical versus mechanistic interaction |
|
|
193 | (1) |
|
14.4 Illustrative example |
|
|
194 | (2) |
|
14.5 Mechanistic interaction defined |
|
|
196 | (1) |
|
|
197 | (1) |
|
14.7 Excess risk and superadditivity |
|
|
197 | (3) |
|
14.8 Conditions under which excess risk and superadditivity indicate the presence of mechanistic interaction |
|
|
200 | (1) |
|
|
201 | (1) |
|
14.10 Back to the illustrative study |
|
|
202 | (2) |
|
14.11 Alternative approaches |
|
|
204 | (1) |
|
|
204 | (4) |
|
|
205 | (1) |
|
|
205 | (1) |
|
|
206 | (2) |
|
15 Ion channels as a possible mechanism of neurodegeneration in multiple sclerosis |
|
|
208 | (10) |
|
|
|
|
|
|
208 | (1) |
|
|
209 | (1) |
|
15.3 The scientific hypothesis |
|
|
209 | (1) |
|
|
210 | (1) |
|
15.5 A simple preliminary analysis |
|
|
211 | (2) |
|
15.6 Testing for qualitative interaction |
|
|
213 | (1) |
|
|
214 | (4) |
|
|
216 | (1) |
|
|
216 | (2) |
|
16 Supplementary variables for causal estimation |
|
|
218 | (16) |
|
|
|
218 | (2) |
|
16.2 Multiple expressions for causal effect |
|
|
220 | (2) |
|
16.3 Asymptotic variance of causal estimators |
|
|
222 | (1) |
|
16.4 Comparison of causal estimators |
|
|
222 | (4) |
|
16.4.1 Supplement C with L or not |
|
|
223 | (1) |
|
16.4.2 Supplement L with C or not |
|
|
224 | (1) |
|
16.4.3 Replace C with L or not |
|
|
225 | (1) |
|
|
226 | (8) |
|
|
226 | (1) |
|
|
227 | (1) |
|
16.A Estimator given all X's recorded |
|
|
227 | (1) |
|
16.B Derivations of asymptotic variances |
|
|
227 | (2) |
|
16.C Expressions with correlation coefficients |
|
|
229 | (1) |
|
|
230 | (1) |
|
16.E Relation between ρ2rl/t and ρ2rl/c |
|
|
231 | (1) |
|
|
232 | (2) |
|
17 Time-varying confounding: Some practical considerations in a likelihood framework |
|
|
234 | (19) |
|
|
|
|
|
234 | (1) |
|
|
235 | (3) |
|
|
235 | (1) |
|
17.2.2 Observed data structure |
|
|
235 | (1) |
|
17.2.3 Intervention strategies |
|
|
236 | (1) |
|
17.2.4 Potential outcomes |
|
|
237 | (1) |
|
17.2.5 Time-to-event outcomes |
|
|
237 | (1) |
|
|
238 | (1) |
|
17.3 Identifying assumptions |
|
|
238 | (1) |
|
17.4 G-computation formula |
|
|
239 | (3) |
|
|
239 | (1) |
|
17.4.2 Plug-in regression estimation |
|
|
240 | (2) |
|
17.5 Implementation by Monte Carlo simulation |
|
|
242 | (1) |
|
17.5.1 Simulating an end-of-study outcome |
|
|
242 | (1) |
|
17.5.2 Simulating a time-to-event outcome |
|
|
242 | (1) |
|
|
242 | (1) |
|
17.5.4 Losses to follow-up |
|
|
243 | (1) |
|
|
243 | (1) |
|
17.6 Analyses of simulated data |
|
|
243 | (6) |
|
|
243 | (1) |
|
17.6.2 Regimes to be compared |
|
|
244 | (1) |
|
17.6.3 Parametric modelling choices |
|
|
245 | (1) |
|
|
246 | (3) |
|
17.7 Further considerations |
|
|
249 | (2) |
|
17.7.1 Parametric model misspecification |
|
|
249 | (1) |
|
|
249 | (1) |
|
17.7.3 Unbalanced measurement times |
|
|
250 | (1) |
|
|
251 | (2) |
|
|
251 | (2) |
|
18 `Natural experiments' as a means of testing causal inferences |
|
|
253 | (20) |
|
|
|
253 | (1) |
|
18.2 Noncausal interpretations of an association |
|
|
253 | (2) |
|
18.3 Dealing with confounders |
|
|
255 | (1) |
|
18.4 `Natural experiments' |
|
|
256 | (10) |
|
18.4.1 Genetically sensitive designs |
|
|
257 | (2) |
|
18.4.2 Children of twins (CoT) design |
|
|
259 | (2) |
|
18.4.3 Strategies to identify the key environmental risk feature |
|
|
261 | (2) |
|
18.4.4 Designs for dealing with selection bias |
|
|
263 | (1) |
|
18.4.5 Instrumental variables to rule out reverse causation |
|
|
264 | (1) |
|
18.4.6 Regression discontinuity (RD) designs to deal with unmeasured confounders |
|
|
265 | (1) |
|
18.5 Overall conclusion on `natural experiments' |
|
|
266 | (7) |
|
|
266 | (1) |
|
18.5.2 Disconfirmed causes |
|
|
267 | (1) |
|
|
267 | (1) |
|
|
268 | (5) |
|
19 Nonreactive and purely reactive doses in observational studies |
|
|
273 | (17) |
|
|
19.1 Introduction: Background, example |
|
|
273 | (4) |
|
19.1.1 Does a dose-response relationship provide information that distinguishes treatment effects from biases due to unmeasured covariates? |
|
|
273 | (1) |
|
19.1.2 Is more chemotherapy for ovarian cancer more effective or more toxic? |
|
|
274 | (3) |
|
19.2 Various concepts of dose |
|
|
277 | (7) |
|
19.2.1 Some notation: Covariates, outcomes, and treatment assignment in matched pairs |
|
|
277 | (1) |
|
19.2.2 Reactive and nonreactive doses of treatment |
|
|
278 | (1) |
|
19.2.3 Three test statistics that use doses in different ways |
|
|
279 | (1) |
|
19.2.4 Randomization inference in randomized experiments |
|
|
280 | (1) |
|
19.2.5 Sensitivity analysis |
|
|
281 | (2) |
|
19.2.6 Sensitivity analysis in the example |
|
|
283 | (1) |
|
|
284 | (3) |
|
19.3.1 What is design sensitivity? |
|
|
284 | (2) |
|
19.3.2 Comparison of design sensitivity with purely reactive doses |
|
|
286 | (1) |
|
|
287 | (3) |
|
|
287 | (3) |
|
20 Evaluation of potential mediators in randomised trials of complex interventions (psychotherapies) |
|
|
290 | (20) |
|
|
|
|
290 | (1) |
|
20.2 Potential mediators in psychological treatment trials |
|
|
291 | (2) |
|
20.3 Methods for mediation in psychological treatment trials |
|
|
293 | (4) |
|
20.4 Causal mediation analysis using instrumental variables estimation |
|
|
297 | (4) |
|
20.5 Causal mediation analysis using principal stratification |
|
|
301 | (1) |
|
20.6 Our motivating example: The SoCRATES trial |
|
|
302 | (3) |
|
20.6.1 What are the joint effects of sessions attended and therapeutic alliance on the PANSS score at 18 months? |
|
|
303 | (1) |
|
20.6.2 What is the direct effect of random allocation on the PANSS score at 18 months and how is this influenced by the therapeutic alliance? |
|
|
304 | (1) |
|
20.6.3 Is the direct effect of the number of sessions attended on the PANSS score at 18 months influenced by therapeutic alliance? |
|
|
305 | (1) |
|
|
305 | (5) |
|
|
306 | (1) |
|
|
307 | (3) |
|
21 Causal inference in clinical trials |
|
|
310 | (17) |
|
|
|
|
310 | (2) |
|
21.2 Causal effect of treatment in randomized trials |
|
|
312 | (4) |
|
21.2.1 Observed data and notation |
|
|
312 | (1) |
|
21.2.2 Defining the effects of interest via potential outcomes |
|
|
312 | (2) |
|
21.2.3 Adherence-adjusted ITT analysis |
|
|
314 | (2) |
|
21.3 Estimation for a linear structural mean model |
|
|
316 | (5) |
|
21.3.1 A general estimation procedure |
|
|
316 | (1) |
|
21.3.2 Identifiability and closed-form estimation of the parameters in a linear SMM |
|
|
317 | (2) |
|
21.3.3 Analysis of the EPHT trial |
|
|
319 | (2) |
|
21.4 Alternative approaches for causal inference in randomized trials comparing experimental treatment with a control |
|
|
321 | (3) |
|
21.4.1 Principal stratification |
|
|
321 | (1) |
|
21.4.2 SMM for the average treatment effect on the treated (ATT) |
|
|
322 | (2) |
|
|
324 | (3) |
|
|
325 | (2) |
|
22 Causal inference in time series analysis |
|
|
327 | (28) |
|
|
|
327 | (1) |
|
22.2 Causality for time series |
|
|
328 | (7) |
|
22.2.1 Intervention causality |
|
|
328 | (3) |
|
22.2.2 Structural causality |
|
|
331 | (1) |
|
|
332 | (2) |
|
|
334 | (1) |
|
22.3 Graphical representations for time series |
|
|
335 | (4) |
|
22.3.1 Conditional distributions and chain graphs |
|
|
336 | (1) |
|
22.3.2 Path diagrams and Granger causality graphs |
|
|
337 | (1) |
|
22.3.3 Markov properties for Granger causality graphs |
|
|
338 | (1) |
|
22.4 Representation of systems with latent variables |
|
|
339 | (4) |
|
|
341 | (1) |
|
|
342 | (1) |
|
22.5 Identification of causal effects |
|
|
343 | (3) |
|
22.6 Learning causal structures |
|
|
346 | (3) |
|
22.7 A new parametric model |
|
|
349 | (2) |
|
|
351 | (4) |
|
|
352 | (3) |
|
23 Dynamic molecular networks and mechanisms in the biosciences: A statistical framework |
|
|
355 | (16) |
|
|
|
355 | (1) |
|
23.2 SKMs and biochemical reaction networks |
|
|
356 | (2) |
|
23.3 Local independence properties of SKMs |
|
|
358 | (4) |
|
23.3.1 Local independence and kinetic independence graphs |
|
|
358 | (3) |
|
23.3.2 Local independence and causal influence |
|
|
361 | (1) |
|
23.4 Modularisation of SKMs |
|
|
362 | (3) |
|
23.4.1 Modularisations and dynamic independence |
|
|
362 | (1) |
|
|
363 | (2) |
|
23.5 Illustrative example - MAPK cell signalling |
|
|
365 | (4) |
|
|
369 | (1) |
|
23.7 Appendix: SKM regularity conditions |
|
|
369 | (2) |
|
|
370 | (1) |
|
|
370 | (1) |
Index |
|
371 | |